Moderna
MRNA
#298
Rank
NZ$142.53 B
Marketcap
NZ$352.27
Share price
-3.17%
Change (1 day)
717.94%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Quarterly Reports

Thumbnail Moderna
 Quarterly Report 2024-q1

Quarterly Report 2024-q1

Language: English

View Quarterly Report
Thumbnail Moderna
 Quarterly Report 2022-q1

Quarterly Report 2022-q1

Language: English

View Quarterly Report
Thumbnail Moderna
 Quarterly Report 2021-q4

Quarterly Report 2021-q4

Language: English

View Quarterly Report
Thumbnail Moderna
 Quarterly Report 2021-q3

Quarterly Report 2021-q3

Language: English

View Quarterly Report
Thumbnail Moderna
 Quarterly Report 2021-q2

Quarterly Report 2021-q2

Language: English

View Quarterly Report
Thumbnail Moderna
 Quarterly Report 2019-q4

Quarterly Report 2019-q4

Language: English

View Quarterly Report
Thumbnail Moderna
 Quarterly Report 2019-q2

Quarterly Report 2019-q2

Language: English

View Quarterly Report
Thumbnail Moderna
 Quarterly Report 2019-q1

Quarterly Report 2019-q1

Language: English

View Quarterly Report